TAR-210 results show 90 percent recurrence-free survival
Updated results reinforce the potential of TAR-210 to transform treatment of non-muscle-invasive bladder cancer with fibroblast growth factor receptor...
Stay updated with breaking news from With Select. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Updated results reinforce the potential of TAR-210 to transform treatment of non-muscle-invasive bladder cancer with fibroblast growth factor receptor...
Investigational TAR-210 first-in-human results highlight the potential for local sustained release of erdafitinib with a novel intravesical delivery...
Investigational TAR-210 first-in-human results highlight the potential for local sustained release of erdafitinib with a novel intravesical delivery system Phase 1 results show a manageable safety profile with limited systemic toxicity, and early complete responses in patients with high-risk and intermediate-risk NMIBC MADRID, Oct. 22, 2023 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & […]
For anyone facing issues with hearing, vision, or other senses, Android’s accessibility options can help bring the outside world closer and allow for forms of interaction that simply wouldn’t be possible without such technology.